HUMMEL ALBERT F
Insider CIK 1236489 · OMPI President & CEO, Director · WPI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACT Actavis, Inc. | G Gift | 2017-09-16 | 2013-09-18 | 3,800 | — | $0 | 88,976 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 82,776 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-09-16 | 2013-09-18 | 6,200 | $137.81 | $854.4K | 82,776 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-26 | 2013-08-26 | 15,956 | $134.44 | $2.15M | 92,776 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-23 | 2013-08-26 | 4,044 | $134.16 | $542.5K | 108,732 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-22 | 2013-08-26 | 20,000 | $134.50 | $2.69M | 112,776 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-13 | 2013-08-15 | 5,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-13 | 2013-08-15 | 5,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-13 | 2013-08-15 | 10,000 | $133.85 | $1.34M | 132,776 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-13 | 2013-08-15 | 5,000 | $29.03 | $145.2K | 137,776 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-13 | 2013-08-15 | 5,000 | $30.12 | $150.6K | 142,776 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-05-10 | 2013-05-14 | 1,877 | — | $0 | 132,776 | SEC↗ |
| OMPI Obagi Medical Products, In | D To issuer deriv | 2013-04-25 | 2013-04-29 | 165,000 | $11.30 | $1.86M | 0 | SEC↗ |
| OMPI Obagi Medical Products, In | D To issuer deriv | 2013-04-25 | 2013-04-29 | 100,000 | $11.45 | $1.15M | 0 | SEC↗ |
| OMPI Obagi Medical Products, In | D To issuer | 2013-04-25 | 2013-04-29 | 65,787 | $24.00 | $1.58M | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-05-29 | 2012-05-29 | 19,000 | $73.74 | $1.40M | 130,899 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-05-11 | 2012-05-14 | 2,887 | — | $0 | 149,899 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-05-02 | 2012-05-04 | 30,000 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-05-02 | 2012-05-04 | 10,679 | $74.73 | $798.0K | 147,012 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-05-02 | 2012-05-04 | 30,000 | $26.60 | $798.0K | 157,691 | SEC↗ |
| OMPI Obagi Medical Products, In | A Award deriv | 2012-05-01 | 2012-05-02 | 165,000 | — | $0 | 265,000 | SEC↗ |